» Articles » PMID: 33570127

Overexpression of Cancer-Associated Stem Cell Gene OLFM4 in the Colonic Epithelium of Patients With Primary Sclerosing Cholangitis

Overview
Specialty Gastroenterology
Date 2021 Feb 11
PMID 33570127
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To examine immune-epithelial interactions and their impact on epithelial transformation in primary sclerosing cholangitis-associated ulcerative colitis (PSC-UC) using patient-derived colonic epithelial organoid cultures (EpOCs).

Methods: The EpOCs were originated from colonic biopsies from patients with PSC-UC (n = 12), patients with UC (n = 14), and control patients (n = 10) and stimulated with cytokines previously associated with intestinal inflammation (interferon (IFN) γ and interleukin (IL)-22). Markers of cytokine downstream pathways, stemness, and pluripotency were analyzed by real-time quantitative polymerase chain reaction and immunofluorescence. The OLFM4 expression in situ was assessed by RNAscope and immunohistochemistry.

Results: A distinct expression of stem cell-associated genes was observed in EpOCs derived from patients with PSC-UC, with lower expression of the classical stem-cell marker LGR5 and overexpression of OLFM4, previously associated with pluripotency and early stages of neoplastic transformation in the gastrointestinal and biliary tracts. High levels of OLFM4 were also found ex vivo in colonic biopsies from patients with PSC-UC. In addition, IFNγ stimulation resulted in the downregulation of LGR5 in EpOCs, whereas higher expression of OLFM4 was observed after IL-22 stimulation. Interestingly, expression of the IL-22 receptor, IL22RA1, was induced by IFNγ, suggesting that a complex interplay between these cytokines may contribute to carcinogenesis in PSC-UC.

Conclusions: Higher expression of OLFM4, a cancer stemness gene induced by IL-22, is present in PSC-UC, suggesting that IL-22 responses may result in alterations of the intestinal stem-cell niche in these patients.

Citing Articles

Combination of inflammatory proteins in serum can be used to diagnose papillary thyroid carcinoma with lymph node metastasis.

Pan Y, Wang G, Chen D, Wu Z, Kei Y, Xu M Discov Oncol. 2025; 16(1):51.

PMID: 39812761 PMC: 11735717. DOI: 10.1007/s12672-025-01793-z.


OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway.

Wei H, Li W, Zeng L, Ding N, Li K, Yu H Mol Cancer. 2024; 23(1):124.

PMID: 38849840 PMC: 11157765. DOI: 10.1186/s12943-024-02016-9.


Comparison of the Cost and Effect of Combined Conditioned Medium and Conventional Medium for Fallopian Tube Organoid Cultures.

Chang Y, Wu K, Harnod T, Ding D Cell Transplant. 2023; 32:9636897231160216.

PMID: 36919683 PMC: 10021093. DOI: 10.1177/09636897231160216.


Cytokine-mediated crosstalk between cancer stem cells and their inflammatory niche from the colorectal precancerous adenoma stage to the cancerous stage: Mechanisms and clinical implications.

Cui G, Wang Z, Liu H, Pang Z Front Immunol. 2022; 13:1057181.

PMID: 36466926 PMC: 9714270. DOI: 10.3389/fimmu.2022.1057181.


Identification of useful genes from multiple microarrays for ulcerative colitis diagnosis based on machine learning methods.

Zhang L, Mao R, Lau C, Chung W, Chan J, Liang F Sci Rep. 2022; 12(1):9962.

PMID: 35705632 PMC: 9200771. DOI: 10.1038/s41598-022-14048-6.


References
1.
Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan A . IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008; 118(2):534-44. PMC: 2157567. DOI: 10.1172/JCI33194. View

2.
Besson D, Pavageau A, Valo I, Bourreau A, Belanger A, Eymerit-Morin C . A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Mol Cell Proteomics. 2011; 10(12):M111.009712. PMC: 3237075. DOI: 10.1074/mcp.M111.009712. View

3.
Zwarycz B, Gracz A, Rivera K, Williamson I, Samsa L, Starmer J . IL22 Inhibits Epithelial Stem Cell Expansion in an Ileal Organoid Model. Cell Mol Gastroenterol Hepatol. 2018; 7(1):1-17. PMC: 6199238. DOI: 10.1016/j.jcmgh.2018.06.008. View

4.
Sarvestani S, Signs S, Lefebvre V, Mack S, Ni Y, Morton A . Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids. Oncotarget. 2018; 9(47):28717-28730. PMC: 6033374. DOI: 10.18632/oncotarget.25617. View

5.
Kirchberger S, Royston D, Boulard O, Thornton E, Franchini F, Szabady R . Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med. 2013; 210(5):917-31. PMC: 3646494. DOI: 10.1084/jem.20122308. View